claim
There is a robust literature of studies establishing the safety and efficacy of ketamine-assisted treatment for depression (Salahudeen et al. 2020) and increasingly high-quality studies on psilocybin-based therapies for depression (Carhart-Harris et al. 2021; Davis et al. 2020), though larger and more robust clinical trials are still needed.

Authors

Sources

Referenced by nodes (3)